ARCHIVES

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

Columbia Next for comprehensive Center Review

February 18, 1977

Charles Balch resigns as ASCO executive vice president; Joseph Bailes named interim EVP.

October 28, 2005

Relative Survival Now May be Over 50%, DeVita Says

December 3, 1982

In Breif: Folkman selected For Karnofsky Lecture; Sporn to give ACS Lecture At ASCO

February 2, 1996

In Brief: FDA Oncology Div. Director Burke To Leave; Reed Is Branch Chief; NCAB Blasts Tobacco

November 4, 1994

DCPC Advisers Ok Four New Grant Programs To Foster Prevention

May 22, 1992